Powered by

Volpara Solutions awarded the US FDA's 510(k) clearance for the updated VolparaDensity clinical breast density assessment

Jan 31, 2019 - Global Banking News

Volpara Solutions Inc revealed on Wednesday the receipt of the US FDA's 510(k) clearance for technologies used in the VolparaDensity clinical breast density assessment within Volpara Enterprise software.

According to the company, the US FDA approved updated version of VolparaDensity accurately reflects breast density from images captured using the Hologic SmartCurve system. This VolparaDensity update supports additional breast imaging systems, including the Siemens Mammomat Fusion and MAMM...